Eye Hospital named as winner of AbbVie’s inaugural Sustainable Healthcare ‘Patients as Partners’ Award
Manchester Royal Eye
Hospital, part of Central Manchester University Hospitals NHS
Foundation Trust (CMFT), has been awarded for the launch and use of
an innovative hand held device for patients which allows risk
factors associated with glaucoma to be detected.
The award, under the category of 'Enabling
patients with technology', was given by AbbVie, a global
biopharmaceutical company, who recently announced the winners of
its inaugural Sustainable Healthcare 'Patients as Partners'
'Patients as Partners'
awards recognise those who have made an exceptional contribution to
the lives of patients and contributed toward a more sustainable
Manchester Royal Eye Hospital was praised for
launching the innovative hand-held device, Icare HOME, which
patients can use themselves to detect raised intraocular pressure -
a key risk factor associated with glaucoma. The use of the device
leads to fewer hospital admissions and less disruption to
day-to-day living for patients.
As a winner in this category, the team will
receive a bursary of up to £3,000 to spend on conference attendance
or research that will benefit patients and/or the NHS.
Karen Cairns, Specialist Glaucoma Nurse, said:
"We are delighted to have been listed to the final 3 and won in the
category 'enabling patients with technology'. It is excellent
recognition for the Manchester Royal Eye Hospital and the Glaucoma
service and team that continually strive to improve patient
experience and clinical outcomes and we are very proud to have
received this award."
This is the first year AbbVie has held the
'Patients as Partners' awards, which were announced at the second
'Going Beyond Medicine' Conference at the King's Fund in London,
held in partnership with the Royal College of Medicine.
The awards were created by AbbVie to recognise,
celebrate and raise awareness of good examples of improvements and
innovation that demonstrate clear benefit to the lives of patients
and make our health services more sustainable, as part of its
Sustainable Healthcare Initiative.
Jane Dwelly, Strategy Director at HIMSS UK and
Head Judge, commented: "The use of a
device that patients can use at home at different times of the day
to measure intraocular pressure will achieve two things. It allows
patients with glaucoma to continue their life without travelling to
clinics to complete a simple test. This means patients will record
more readings than before."
Over 70% of the NHS budget, or £7 out of every
£10, goes on care for people living with long-term conditions.
[i] To tackle this challenge, AbbVie has invested in its
Sustainable Healthcare Initiative since 2014, to develop
solutions to help make health services sustainable for the future
and help people living with long-term conditions get better
outcomes and to better use resources.
Matt Regan, UK General Manager, AbbVie
commented: "We are proud to recognise the people and
organisations that are making a real difference to both patients
and the healthcare system in the UK. If together we can help the
NHS to better support people with long-term conditions, not only
will people have better health outcomes but resources will be
better used and the service will make headway towards meeting the
[i] Department of Health, Long term conditions compendium
of information - third edition, May 2012, page 3